BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16614141)

  • 1. Update on anticoagulant medications for the interventional radiologist.
    Mehta RP; Johnson MS
    J Vasc Interv Radiol; 2006 Apr; 17(4):597-612. PubMed ID: 16614141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New anticoagulant drugs: monitoring and perioperative strategies.
    Ickx BE
    Acta Anaesthesiol Belg; 2006; 57(4):409-18. PubMed ID: 17236644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 7. Belgian guidelines concerning central neural blockade in patients with drug-induced alteration of coagulation: an update.
    Vandermeulen E; Singelyn F; Vercauteren M; Brichant JF; Ickx BE; Gautier P; ;
    Acta Anaesthesiol Belg; 2005; 56(2):139-46. PubMed ID: 16013658
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of surgical patients receiving anticoagulation and antiplatelet agents.
    Thachil J; Gatt A; Martlew V
    Br J Surg; 2008 Dec; 95(12):1437-48. PubMed ID: 18991253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Where to look for progress in antithrombotic treatments?].
    Samama MM
    Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of anticoagulation.
    Hoppensteadt DA; Jeske W; Walenga J; Fareed J
    Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].
    Páramo JA; García R; Rodríguez P; de Gaona ER
    Rev Med Univ Navarra; 2007; 51(1):23-7. PubMed ID: 17555117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiplatelet agents and anticoagulants: management of the anticoagulated surgical patient].
    Llau JV; Ferrandis R; López Forte C
    Cir Esp; 2009 Jun; 85 Suppl 1():7-14. PubMed ID: 19589404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antithrombotic agents: are they needed and what can they offer to patients with a non-ST-elevation acute coronary syndrome?
    Van de Werf F
    Eur Heart J; 2009 Jul; 30(14):1695-702. PubMed ID: 19491132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of the anticoagulant and antithrombotic medications used in the treatment of acute coronary syndrome (ACS).
    Albritton S; Shuler L; Schatz K
    Crit Care Nurse; 2001 Aug; 21(4):75-7. PubMed ID: 11858692
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: a review.
    Girolami B; Girolami A
    Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet activation in acute coronary syndrome and interventional therapy].
    Bigalke B; Lindemann S; Gawaz M
    Hamostaseologie; 2007 Dec; 27(5):338-43. PubMed ID: 18060243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antithrombotic strategies in cardiovascular diseases.
    Golino P; Loffredo F; Riegler L; Renzullo E; Cocchia R
    Curr Opin Investig Drugs; 2005 Mar; 6(3):298-306. PubMed ID: 15816507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifty years of experience with antithrombotic therapy in cardiac disease. A 1996 approach based on pathogenesis and risk.
    Freudenberger RS; Fuster V
    Mt Sinai J Med; 1996; 63(5-6):342-58. PubMed ID: 8898540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.